iPLEDGE

iPLEDGE is a safety program mandated by the FDA for patients taking isotretinoin, a powerful medication for severe acne. It aims to prevent birth defects by ensuring women of childbearing age use effective contraception during treatment and undergo regular pregnancy testing. Patients, healthcare providers, and pharmacies must register and adhere to strict guidelines, including counseling on risks and reporting pregnancy status. This system helps ensure safe use of isotretinoin, balancing its benefits with potential serious risks to unborn children.